Dana-Farber Cancer Institute

This is your central portal for breaking news, the latest research and important updates from Dana-Farber Cancer Institute. Bookmark this page and check back often for updates.

Meeting NewsPerspective

Surgery choice affects quality of life among younger patients with breast cancer

December 7, 2018
SAN ANTONIO — Local therapy decisions appeared to significantly affect quality of life among young breast cancer survivors, according to study…
Meeting NewsPerspective

Researchers identify gene alterations linked to certain metastatic breast cancers

December 5, 2018
SAN ANTONIO — Ten driver gene alterations appeared more common among a cohort of patients with metastatic hormone receptor-positive…
Meeting NewsPerspective

Shorter chemotherapy course 'equally effective' in diffuse large B-cell lymphoma

December 2, 2018
SAN DIEGO — Reducing administration of CHOP chemotherapy by two cycles appeared as effective as the standard six cycles for younger patients…
Meeting NewsPerspective

Pembrolizumab demonstrates ‘robust’ activity in relapsed, refractory primary mediastinal large B-cell lymphoma

December 2, 2018
SAN DIEGO — Pembrolizumab demonstrated considerable antitumor activity among patients with relapsed or refractory primary mediastinal large…
Meeting NewsPerspective

Autologous gene therapy shows promise for sickle cell disease

December 2, 2018
SAN DIEGO — An adult with sickle cell disease responded positively to autologous gene therapy, providing the first proof that this approach…
Meeting NewsPerspective

Ibrutinib alone, with rituximab improves PFS in chronic lymphocytic leukemia

December 1, 2018
SAN DIEGO — The use of ibrutinib alone or with rituximab prolonged PFS compared with bendamustine plus rituximab among previously untreated…
Meeting NewsPerspective

Luspatercept effectively treats anemia in transfusion-dependent myelodysplastic syndrome

December 1, 2018
SAN DIEGO — Luspatercept significantly reduced the transfusion burden compared with placebo among patients with anemia due to myelodysplastic…
Feature

Trove of brain cancer data available for study through Georgetown platform

November 27, 2018
One of the largest collections of brain cancer biomedical data in the United States is now available for study through the open access Georgetown…
Cover Story

Advances in myeloma treatments, diagnostics have specialists ‘talking about cure’

HemOnc Today, November 25, 2018
A decade ago, patients with newly diagnosed multiple myeloma typically survived 3 to 5 years. However, the development of highly effective therapies…
Meeting News

Sarcoma treatments evolve as understanding of disease biology improves

November 7, 2018
NEW YORK — The treatment landscape in sarcoma is evolving rapidly as the research community recognizes the importance of matching therapies to…

ESMO honors several oncology leaders

October 31, 2018
European Society for Medical Oncology honored several oncology leaders during its annual congress. Jean-Charles Soria, MD, PhD, received the…

Survey: 4 in 10 Americans believe alternative treatments can cure cancer

October 30, 2018
About four in 10 Americans believe cancer can be cured solely through alternative therapies, according to ASCO’s second annual National Cancer…

Oncologists, hematologists elected to National Academy of Medicine

October 18, 2018
The National Academy of Medicine announced the election of 75 regular members and 10 international members. Election to the academy —…

Three researchers to be honored at San Antonio Breast Cancer Symposium

October 14, 2018
Three highly regarded researchers will be honored at this year’s San Antonio Breast Cancer Symposium, scheduled for Dec. 4-8. Ian
Meeting News

LOXO-292 safe, effective for RET-altered non-small cell lung cancer

September 27, 2018
LOXO-292 appeared well tolerated and demonstrated antitumor activity among patients with heavily pretreated RET fusion-positive non-small cell lung…
In the Journals Plus

High-dose chemotherapy improves survival in Ewing sarcoma

September 21, 2018
A high-dose combination of busulfan and melphalan with autologous stem cell transplant improved survival compared with standard-of-care vincristine…

Prostate Cancer Foundation presents Young Investigator Awards

September 2, 2018
The Prostate Cancer Foundation granted $6 million to 29 early-career scientists through its Young Investigator Awards program. “We are honored…
FDA News

FDA approves Imbruvica plus Rituxan for Waldenström’s macroglobulinemia

August 27, 2018
The FDA approved ibrutinib in combination with rituximab for the treatment of adults with Waldenström’s macroglobulinemia.

ASH to honor several leaders in hematology

August 26, 2018
Several leaders in hematology will be honored through awards and special lectures at ASH Annual Meeting and Exposition, scheduled for Dec. 1-4 in San…

The University of Texas MD Anderson Cancer Center ranked best cancer hospital in country

August 14, 2018
The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country. MD Anderson tops U.S